Ahmed MH, Osman MM. 2006. Improving laboratory diagnosis of diabetic nephropathy with the use of glomerular filtration rate. Diabetes Technol Ther, 8: 688-690.
Akowuah GA, Sadikun A, Mariam A. 2002. Flavonoid identifi-cation and hypoglycaemic studies of the butanol fraction from Gynura procumbens. Pharm Biol, 40: 405-410.
Alderson NL, Chachich ME, Frizzell N, Canning P, Metz TO et al. 2004. Effect of antioxidants and ACE inhibition on chemical modification of proteins and progression of nephropathy in streptozotocin diabetic rat. Diabetologia, 47: 1385-1395.
Arayne MS, Sultana N ,Bahadur SS. 2007. The berberis story: Berberis vulgaris in therapeutics. Pak J Sci, 20: 83-92.
Doggrell SA. 2005. Berberine-a novel approach to cholesterol lowering. Expert Opinion Investing Drugs, 14: 683-685.
Edem DO. 2009. Hypoglycemic effects of ethanolic extracts of Alligator Pear Seed (Persea Americana Mill) in rats. Eur J Sci Res, 33: 669-678.
Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, et al. 2008. Ptevalence of diabetes and impaired fasting glucose in the adult population of iran:National Survey of Risk Faktors for Non Communicable Diseases of Iran. Diabetes-care, 31: 96-98.
Floretto P, Steffes MW, Sutherland ERD, Goetz CF, Mauer M. 1998. Reversal of lesions of diabetic nephropathy after pancreas transplantation. NEJM, 339: 69-75.
Gandhimathi R, Sreedevi A. 2012. Cerebro-protective effect of synedrella nodiflora linn. against cerebral ischemia in rats. Int J of Pharmacol Res, 2: 16-21.
Gilgun-Sherki Y, Melamed E, Offen D. 2001. Oxidative stress induced neuro-dengenerative diseases: The need for antioxidants that penetrate the blood brain barrier. Neuropharmacology, 40:959-75.
Giorgino F, Lavida L, Cavallo PP, Solnica B, Fuller J, et al. 2004. Factors associated with progression to macroalbuminuria in microalbuminuria type 1 patients: Eurodiab prospective and complications study. Diabetologia, 4: 1413-1418.
Haneda M. 2006. Mechanisms for the development and progression of diabetic nephropathy. Nippon Rinsho, 64: 427-432.
Hosseinzadeh H, Ramzani M, Danaei AR. 2002. Antihyperglysemic effect and acute toxicity of Securigera securidaca L. seed Extracts in mice. Phyto Res, 16: 745-747.
Ivanovska N, Phlipov S. 1999. Study on the anti-inflammatory action of berberis vulgaris root extract, alkaloid fractions and pure alkaloid. Int J Ethnopharmacol, 64: 161-166.
Kazemi S, Asgary S, Moshtaghian J, Rafieian M, Adelnia A, et al. 2010. Liver-protective effects of hydroalcoholic extract of Allium Hirtifolium Boiss in rats with alloxan-induced diabetes mellitus. ARYA Atherosclerosis Journal, 6: 11-15.
Ko BS, Choi SB, Park SK, Jang JS, Kim YE, et al. 2005. Insulin sensitizing and insulinotropic action of berberine from Cortidis Rhizoma. Biol Pharm Bull, 28: 1431-1437.
Kumar S, Kumar D, Rakash O. 2008. Evaluation of antioxidant potential, phenolic and flavonoid contents of hibiscus liliaceous flowers.
EJAF, 7: 2863-2871.
Levey AS. 2002. Nondiabetic kidney disease. N Engl J Med, 347: 1505-1511.
Li WL, Zheng HC, Bukuru J, De KN. 2004. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol, 92: 1-21
Liu W, Hei Z, Nie H, Tang F, Huang H, et al. 2008. Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. Chin Med J, 121: 706-712.
Mahalingam G, Krishnan K. 2008. Anti-diabetic and Ameliorative Potential of Ficus bengalensis Bark extract in Streptozotocin- induced diabetic rats. Ind J of Clin Bioch, 23: 394-400.
Manickam M, Ramanathan M, Jahromi MA, Chansouria JP, Ray AB. 1997. Antihyperglycaemic activity of phenolics from Pterocarpus marsupium, J Nat Prod, 60: 609-610.
Mauer SM, Steffes MW, Brown DM.1981. The kidney in diabetes. Am J Med, 70:603-612.
Nawel M, Mohamed E, Amine D, Hocine A, Boufeldja T. 2011. Hypoglycaemic effect of Berberis vulgaris L. in normal and streptozotocin-induced diabetic rats. Asian Pac J Trop Biomed, 468-471.
NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases). 2007. Kidney.
Rashki KM, Gol A, Dabiri SH. 2009. Preventive Effects of Garlic Juice on Renal Damages Induced by Diabetes Mellitus in Rats. Iran J Endocrinol Metab, 13: 331-339.
Renu A, Saiyada NA, Odenbach S. 2004. Effect of reinstitution of good metabolic control on oxidative stress in kidney of diabetic rats. J Diab Compl, 5: 282-288.
Rosolowsky ET, Niewczas MA, Ficociello LH, Perkins BA, Warram JH, et al. 2008. Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy. Diabetes Res Clin Pract, 13: 46-53.
Sabir M, Akhter MH, Bhide NK. 1978. Ffurther studies on pharmacology of berberin. India J Physio Pharmacol, 22: 9-13.
Sancheti S, Sancheti S, Bafna M, Seo SY. 2010. Antihyperglycemic, antihyperlipidemic, and antioxidant effects of Chaenomeles sinensis fruit extract in streptozotocin induced diabetic rats. Eur Food Res Technol, 231:415-421.
Sharma S, Kulkarni SK, Chopra K. 2006. Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol, 33: 940-5.
Si FX, Yang DS, Wang BX. 2005. Renal protection of berberine and its mechanism in type diabetic rats. Heilongjiang Med Pharmacy (Chin), 28: 10-12.
Stambe C, Atkins RC, Tesch GH, Kapoun AM, Hill PA, et al. 2003. Blockade of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis. J Am Soc Nephrol, 14: 338-351.
Sun JE, Ao ZH, Lu ZM, Xu HY, Zhang XM, et al. 2008. Antihyperglycemic and antilipidperoxidative effects of dry matter of culture broth of Inonotus obliquus in submerged culture on normal and alloxan-diabetes mice. J Ethnopharmacol, 118:7-13.
Wild S, Roglic G, Green A, Sicree R, King H. 2004. Global prevalence of diabetes: estimates for the year 2000 and projecttions for 2030. Diabetjutjtes Care, 27: 1047-1053.
Yin I, Hu R, Chen M, Tang J, Li F, et al. 2002. Effects of berberine on glucose metabolism in vitro. Metabolism, 51: 1439-1443.